Vimarsana
Biggest News Aggregation in the World

Page 4 - Alrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alrn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alrn Today - Breaking & Trending Today

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Declines By 17.0% - Vimarsana News

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Declines By 17.0%

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 153,600 shares, a drop of 17.0% from the April 15th total of 185,100 shares. Based on an average daily trading volume, of 360,700 shares, the days-to-cover ratio […]

Aileron Therapeutics (NASDAQ:ALRN) Downgraded to "Hold" at Zacks Investment Research - Vimarsana News

Aileron Therapeutics (NASDAQ:ALRN) Downgraded to "Hold" at Zacks Investment Research

Zacks Investment Research downgraded shares of Aileron Therapeutics (NASDAQ:ALRN – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in […]

Aileron Therapeutics' (ALRN) "Buy" Rating Reiterated at HC Wainwright - Vimarsana News

Aileron Therapeutics' (ALRN) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Aileron Therapeutics (NASDAQ:ALRN – Get Rating) in a research report released on Tuesday morning, Zacks.com reports. Separately, Zacks Investment Research raised Aileron Therapeutics from a sell rating to a hold rating in a research report on Tuesday, January 4th. Shares of NASDAQ:ALRN opened at $0.55 on […]

Aileron Therapeutics (NASDAQ:ALRN) Announces Quarterly Earnings Results - Vimarsana News

Aileron Therapeutics (NASDAQ:ALRN) Announces Quarterly Earnings Results

Aileron Therapeutics (NASDAQ:ALRN – Get Rating) released its quarterly earnings data on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.08), MarketWatch Earnings reports. Shares of ALRN stock opened at $0.53 on Tuesday. The stock’s fifty day moving average is $0.43 and its 200-day moving average […]